| Phytochemical Name | Quercetin |
| PubChem CID | 5280343 |
| Disease Indication | Chronic obstructive pulmonary disease [ICD-11: CB40] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Anti-PD-1 antibody; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Fluorouracil; Oxaliplatin |
| Source |
Cool
Camellia sinensis
Cold
Euphorbia pekinensis;
|
| Phytochemical Name | Epigallocatechin gallate |
| PubChem CID | 65064 |
| Disease Indication | Breast cancer [ICD-11: 2C60] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Acetaminophen; Bortezomib; Doxorubicin; Fluorouracil; Gefitinib; Irinotecan; Metformin; Osimertinib; TNF-related apoptosis inducing ligand; Vorinostat |
| Source |
Cool
Camellia sinensis
|
| Phytochemical Name | (-)-Catechin gallate |
| PubChem CID | 6419835 |
| Disease Indication | Hepatocellular carcinoma [ICD-11: 2C12] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Sorafenib |
| Source |
Warm
Rubus chingii Hu;
Cool
Camellia sinensis
|
| Phytochemical Name | Cianidanol |
| PubChem CID | 9064 |
| Disease Indication | Diabetes [ICD-11: 5A14] Phase 1 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Fluorouracil; Hydroxyl-chloroquine; Irinotecan |
| Source |
Cool
Camellia sinensis
|
| Phytochemical Name | Theaflavin 3,3'-digallate |
| PubChem CID | 21146795 |
| Disease Indication | Ovarian cancer [ICD-11: 2C73] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cisplatin; Trastuzumab |
| Source |
Cool
Camellia sinensis
|
| Phytochemical Name | Tea polyphenol |
| Disease Indication | Parkinson's disease [ICD-11: 8A00] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Paclitaxel |
| Source |
Cool
Camellia sinensis
|
| Phytochemical Name | Oxidized tea polyphenol |
| Disease Indication | Obesity [ICD-11: 5B81] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Nimotuzumab; Sildenafil |
| Source |
Cool
Camellia sinensis
|
| Phytochemical Name | Quercetin |
| PubChem CID | 5280343 |
| Disease Indication | Chronic obstructive pulmonary disease [ICD-11: CB40] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Anti-PD-1 antibody; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Fluorouracil; Oxaliplatin |
| Source |
Cool
Camellia sinensis
Cold
Euphorbia pekinensis;
|
| Phytochemical Name | Epigallocatechin gallate |
| PubChem CID | 65064 |
| Disease Indication | Breast cancer [ICD-11: 2C60] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Acetaminophen; Bortezomib; Doxorubicin; Fluorouracil; Gefitinib; Irinotecan; Metformin; Osimertinib; TNF-related apoptosis inducing ligand; Vorinostat |
| Source |
Cool
Camellia sinensis
|
| Phytochemical Name | (-)-Catechin gallate |
| PubChem CID | 6419835 |
| Disease Indication | Hepatocellular carcinoma [ICD-11: 2C12] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Sorafenib |
| Source |
Warm
Rubus chingii Hu;
Cool
Camellia sinensis
|
